Predictive value of proinflammatory activation in prognosis of cardiovascular events after treatment of chronic lymphoid leukemia
Aim: To evaluate the prognostic value of circulating interleukin-6 and CD40 ligand in patients after chronic lymphoid leukemia treatment. Materials and Methods: 193 patients with chronic lymphoid leukemia after chemotherapy were included in the study. Observation period was up to 12 months. Blood...
Saved in:
| Main Author: | B. B. Samura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2017-06-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/100614/97158 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01) -
Analysis of lymphocytic leukemia trends among gender, race, age, and regional groups in the U.S. between 1999-2022: a CDC-WONDER database study
by: Shannon Blee, et al.
Published: (2025-05-01) -
Tertiary Lymphoid Structures and Cancer Prognosis (Brief Review)
by: R. A. Rustamkhanov, et al.
Published: (2020-01-01) -
Value of circulating galectin-3 for prognosis of cardiovascular events in patients with chronic lymphocytic leukemia in remission
by: B. B. Samura, et al.
Published: (2014-12-01) -
Serum Levels of IL-6 Type Cytokines and Soluble IL-6 Receptors in Active B-Cell Chronic Lymphocytic Leukemia and in Cladribine Induced Remission
by: T. Robak, et al.
Published: (1999-01-01)